Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, R. M.

Chest, Vol 88, 900-905, Copyright © 1985 by American College of Chest Physicians

REVIEWS

Pulmonary oxygen toxicity

RM Jackson

Although oxygen therapy has been used in the care of critically ill patients for many years, the recognition of pulmonary oxygen toxicity as an important clinical problem is relatively recent. The biochemical basis of oxygen toxicity is increased production of highly reactive, partially reduced metabolites of oxygen, including hydrogen peroxide and free radicals, by cells in hyperoxia. Enzymatic intracellular defense mechanisms exist which protect cells from the toxic effects of oxygen free radicals. The physiologic manifestations of oxygen toxicity include decreases in vital capacity, diffusing capacity, and lung compliance. The pathologic changes of oxygen toxicity are not specific and resemble those of the adult respiratory distress syndrome. Many drugs used in the care of patients, including bleomycin, nitrofurantoin, and corticosteroids, may exacerbate oxygen-induced lung injury. No effective pharmacologic means exist for lessening pulmonary oxygen toxicity in humans.


This article has been cited by other articles:


Home page
 J. Histochem. Cytochem.Home page
T. G. Brock and C. Di Giulio
Prolonged Exposure to Hyperoxia Increases Perivascular Mast Cells in Rat Lungs
J. Histochem. Cytochem., November 1, 2006; 54(11): 1239 - 1246.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. I. Ellman, J. S. Alvis, C. Tache-Leon, R. Singh, T. B. Reece, J. A. Kern, C. G. Tribble, and I. L. Kron
Hyperoxic ventilation exacerbates lung reperfusion injury
J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1440 - 1440.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
T. Fujita, M. Maruyama, J. Araya, K. Sassa, Y. Kawagishi, R. Hayashi, S. Matsui, T. Kashii, N. Yamashita, E. Sugiyama, et al.
Hydrogen Peroxide Induces Upregulation of Fas in Human Airway Epithelial Cells via the Activation of PARP-p53 Pathway
Am. J. Respir. Cell Mol. Biol., November 1, 2002; 27(5): 542 - 552.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Wu, Y.-H. He, M. Kobune, Y. Xu, M. R. Kelley, and W. J. Martin II
Protection of Human Lung Cells against Hyperoxia Using the DNA Base Excision Repair Genes hOgg1 and Fpg
Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 192 - 199.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. T. Chapman, L. E. Otterbein, J. A. Elias, and A. M. K. Choi
Carbon monoxide attenuates aeroallergen-induced inflammation in mice
Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L209 - L216.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
Y. Lu, L. Parkyn, L. E. Otterbein, Y. Kureishi, K. Walsh, A. Ray, and P. Ray
Activated Akt Protects the Lung from Oxidant-induced Injury and Delays Death of Mice
J. Exp. Med., February 20, 2001; 193(4): 545 - 550.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
H. R Gosker, E. F. Wouters, G. J van der Vusse, and A. M. Schols
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives
Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1033 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
F. J. Saldias, A. Comellas, K. M. Ridge, E. Lecuona, and J. I. Sznajder
Isoproterenol improves ability of lung to clear edema in rats exposed to hyperoxia
J Appl Physiol, July 1, 1999; 87(1): 30 - 35.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. Yoshida, M. Maruyama, T. Fujita, N. Arai, R. Hayashi, J. Araya, S. Matsui, N. Yamashita, E. Sugiyama, and M. Kobayashi
Reactive oxygen intermediates stimulate interleukin-6 production in human bronchial epithelial cells
Am J Physiol Lung Cell Mol Physiol, June 1, 1999; 276(6): L900 - L908.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
L. P. Zheng, R. S. Du, and B. E. Goodman
Effects of acute hyperoxic exposure on solute fluxes across the blood-gas barrier in rat lungs
J Appl Physiol, January 1, 1997; 82(1): 240 - 247.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Corroyer, B. Maitre, V. Cazals, and A. Clement
Altered Regulation of G1 Cyclins in Oxidant-induced Growth Arrest of Lung Alveolar Epithelial Cells. ACCUMULATION OF INACTIVE CYCLIN E-CDK2 COMPLEXES
J. Biol. Chem., October 11, 1996; 271(41): 25117 - 25125.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American College of Chest Physicians.